Forty years of research on emerging viral diseases.
DOI:
https://doi.org/10.62954/d78c5n32Keywords:
emerging viral diseasesAbstract
A disease or microorganism is classified as emerging when the causative agent or the disease it causes has appeared for the first time within a population. Re-emerging diseases, on the other hand, are caused by variants of known infectious agents, when their incidence, virulence, or geographic reach has increased dramatically.
References
Reyes-Leyva J, Espinosa B, Hernández J, Zenteno R, Vallejo V, Hernández-Jáuregui P, Zenteno E. NeuAc alpha2,3Gal-glycoconjugate expression determines cell susceptibility to the porcine rubulavirus LPMV. Comp Biochem Physiol 1997; 118B: 327-332.
Santos-López G, Flores E, Baños R, Herrera-Camacho I, Reyes-Leyva J. Purification of the Porcine rubulavirus attachment protein by liquid isoelectric focusing. Protein Expr Purif 2004; 35: 120-125.
Santos-López G, Cruz C, Pazos N, Vallejo V, Reyes-Leyva J, Tapia-Ramírez J. Two clones obtained from Urabe AM9 mumps virus vaccine differ in their replicative efficiency in neuroblastoma cells. Microb Infect 2006, 8: 332-339. doi: 10.1016/j.micinf.2005.06.031
Reyes-Leyva J, Baños R, Borraz-Argüello M, Santos-López G, Rosas N, Alvarado G, Herrera-Camacho I, Vallejo V, Tapia-Ramírez J. Amino acid change 335 E to K affects the sialic-acid-binding and neuraminidase activities of Urabe AM9 mumps virus hemagglutinin-neuraminidase glycoprotein. Microb Infect 2007, 9: 234-240. doi: 10.1016/j.micinf.2006.11.011
Rosas-Murrieta N, Herrera-Camacho I, Vallejo-Ruíz V, Millán Perez-Peña L, Tapia-Ramirez J, Santos-López G, Reyes-Leyva J. Differential sensitivity to interferon influences the replication and transcription of Urabe AM9 mumps virus variants in nerve cells. Microb Infect 2007, 9: 864-872 doi: 10.1016/j.micinf.2007.03.005.
Sedeño-Monge V, Santos-López G, Rocha-Gracia RC, Meléndez-Mena D, Ramírez-Mata A, Vallejo-Ruiz V, Reyes-Leyva J. Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C. Virol J 2010, 7:243
Melendez-Mena D, Mendoza-Torres MA, Sedeño-Monge V, García Y García VH, Rivera-García E, Sánchez-Reza L, Baxin Domínguez MDC, Guzmán-Flores B, Martinez-Laguna Y, Coronel Espinoza JM, Galindo-Santiago I, Flores-Alonso JC, Vallejo-Ruiz V, Cortes-Hernandez P, Reyes-Leyva J, Sosa-Jurado F, Santos-López G. Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy. PeerJ. 2021 Sep 17;9:e12051. doi: 10.7717/peerj.12051
Sosa-Jurado F, Sánchez-Reza L, Mendoza-Torres MÁ, Meléndez-Mena D, García VHGY, Guzmán-Flores B, Enciso-Moreno JA, López-Ramos JE, Balandrán JC, Vallejo-Ruiz V, Cortes-Hernández P, Reyes-Leyva J, Santos-López G. Serum Th17 and TNF-α distinguish between patients with occult hepatitis B infection, chronic hepatitis B infection and healthy individuals. Eur Cytokine Netw. 2021 Jun 1;32(2):23-30. doi: 10.1684/ecn.2021.0466.
Flores-Mendoza LK, Estrada-Jiménez T, Sedeño-Monge V, Moreno M, Manjarrez MDC, González-Ochoa G, Millán-Pérez Peña L, Reyes-Leyva J. IL-10 and socs3 are predictive biomarkers of dengue hemorrhagic fever. Mediators Inflamm 2017;2017:5197592. doi: 10.1155/2017/5197592.
Jasso-Miranda C, Herrera-Camacho I, Flores-Mendoza LK, Dominguez F, Vallejo-Ruiz V, Sanchez-Burgos GG, Pando-Robles V, Santos-Lopez G, Reyes-Leyva J. Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies. Infect Drug Resist 2019 Jul 1;12:1833-1852. doi: 10.2147/IDR.S210890.
Estrada-Jiménez T, Flores-Mendoza L, Ávila-Jiménez L, Vázquez-Rodríguez CF, Sánchez-Burgos GG, Vallejo-Ruiz V, Reyes-Leyva J. Low Activation of CD8 T Cells in response to Viral Peptides in Mexican Patients with Severe Dengue. J Immunol Res 2022 Mar 25;2022:9967594. doi: 10.1155/2022/9967594.
Romo-Rodríguez R, Gutiérrez-de Anda K, López-Blanco JA, et al. Chronic Comorbidities in Middle Aged Patients Contribute to Ineffective Emergency Hematopoiesis in Covid-19 Fatal Outcomes. Arch Med Res. 2023 Apr;54(3):197-210. doi: 10.1016/j.arcmed.2023.03.003.
Montalvo-Corral M, Reséndiz M, Santos-López G, Vallejo-Ruíz V, Reyes-Leyva J, Hernández J. Estandarización de un método de detección molecular del virus influenza (H5N1) de alta patogenicidad. Acta Bioquímica Clínica Latinoamericana 2009, 43:49-52.
Toledo-Rueda W, Rosas-Murrieta NH, Muñoz-Medina JE, González-Bonilla CR, Reyes-Leyva J, Santos-López G. Antiviral resistance markers in influenza virus sequences in Mexico, 2000-2017. Infect Drug Resist 2018 Oct 11;11:1751-1756. doi: 10.2147/IDR.S153154.
Márquez-Domínguez L, Reyes-Leyva J, Herrera-Camacho I, Santos-López G, Scior T. Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus. Molecules. 2020 Sep 16;25(18):4248. doi: 10.3390/molecules25184248.
Márquez Domínguez L, Márquez Matla K, Reyes Leyva J, Vallejo Ruíz V, Santos López G. Antiviral resistance in influenza viruses. Cell Mol Biol (Noisy-le-grand) 2023 Dec 10;69(13):16-23. doi: 10.14715/cmb/2023.69.13.3.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Julio Reyes Leyva (Autor/a)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
